Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuRx Medical
AddedFeb 18, 2024
UpdatedJun 18, 2026
NeuRx Medical

NeuRx Medical

Angel

NeurRx Medical: Innovating thrombectomy tech for rapid clot treatment in stroke and vascular cases.

HQ
Philadelphia, PA, US
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize vascular treatment, NeuRx Medical focuses on developing advanced percutaneous thrombectomy technologies. The company aims to address critical gaps in current systems by providing devices that enable endovascular specialists to achieve rapid clot stabilization, retention, and retrieval during image-guided procedures. NeuRx Medical's primary market includes patients suffering from ischemic stroke, deep vein thrombosis (DVT), and other vascular conditions.

Notable figures affiliated with NeuRx Medical include leading experts in vascular medicine and medical device innovation. The company has garnered attention from key investors in the healthcare technology sector. Among its significant achievements, NeuRx Medical has developed cutting-edge thrombectomy devices that have shown promise in improving patient outcomes and survival rates following large vessel occlusion strokes. The overall impact of NeuRx Medical's innovations is poised to transform the landscape of stroke and vascular treatment, offering new hope to hundreds of thousands of patients annually.

NeuRx Medical - Similar Companies

Cognition Medical logo

Cognition Medical

Neurvana Medical logo

Neurvana Medical

Rapidpulse logo

Rapidpulse

rapidpulsemed.com

NeuroVasc Technologies logo

NeuroVasc Technologies

Progressive Nuero logo

Progressive Nuero

Nectero Medical logo

Nectero Medical

necteromed.com

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

NeuroVasx logo

NeuroVasx

StrokeDx logo

StrokeDx

stroke-dx.com

FastWave Medical logo

FastWave Medical

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

Galaxy Therapeutics logo

Galaxy Therapeutics

Euphrates Vascular logo

Euphrates Vascular

NeuraMedica logo

NeuraMedica

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

NeuRx Medical - Quick Facts

Who are NeuRx Medical's competitors?

Companies similar to NeuRx Medical include Cognition Medical, Neurvana Medical, Rapidpulse and NeuroVasc Technologies.

Where is NeuRx Medical's headquarters located?

NeuRx Medical's headquarters is located in Philadelphia, PA, US.

When was NeuRx Medical's last funding round?

NeuRx Medical's most recent funding round was for $256k (USD) in March 2022.

How much has NeuRx Medical raised to-date?

As of Mar 6, 2022, NeuRx Medical has raised a total of $256k (USD).

How many employees does NeuRx Medical have?

NeuRx Medical has 1 employee as of Feb 4, 2024.

NeuRx Medical - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified